10 Nov, 2026

Breast cancer pill from AstraZeneca misses mark in pivotal study

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — AstraZeneca said Friday that a breast cancer pill failed in a pivotal trial testing it as a first-line therapy in advanced tumors, a result that could limit the use of the […]

2 mins read

Mark 8 years: sincere tribute from Lazerian to attack the Manchester 22 Arena

Today has marked eight years since the bombing of the Manchester Arena – a tragic event that took 22 lives and injured much more on May 22, 2017. It was a moment that left the city in shock, but also revealed strength and resilience for which Manchester is known. In the morning after the attack, […]

2 mins read